ERP29 and colorectal carcinoma: Interestingly, these results, from lenti shRNA ERP29 and shRNA FUMH alone CRC, showed ERP29 and FUMH protected CRC cells from a reduction of malignancy to promote metastasis and may be a potential effect of medical intervention for CRC therapy (Table 2).